Baader Bank Aktiengesellschaft’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,630	Closed	-$435	–	423
2023 Q4	$435	Buy	+10,630	New	+$892	﹤0.01%	319

Other funds holding NAVB

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Baader Bank Aktiengesellschaft's NAVB Position: Q1 2024 in Review

Baader Bank Aktiengesellschaft sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q1 2024, closing a stake of 10,630 shares — an estimated $435 sold.

Baader Bank Aktiengesellschaft first reported a position in NAVB in Q4 2023 and held it in 1 quarter. The position peaked at $435 in Q4 2023. 2 funds tracked by Wall St. Rank hold NAVB as of Q1 2024.

Baader Bank Aktiengesellschaft reported no remaining Navidea Biopharmaceuticals Inc. position as of Q1 2024 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 10,630 Navidea Biopharmaceuticals Inc. shares in Q1 2024, an estimated $435.
Baader Bank Aktiengesellschaft first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2023 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's Navidea Biopharmaceuticals Inc. position peaked at $435 in Q4 2023.
2 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q1 2024.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2024, filed 3 May 2024.